UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059478
Receipt number R000067826
Scientific Title Genetic Counseling to Support Couples' Decision-Making Regarding Prenatal Testing: A Randomized Controlled Trial Using the Ottawa Decision Guide
Date of disclosure of the study information 2025/10/20
Last modified on 2025/10/20 21:46:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Genetic Counseling to Support Couples' Decision-Making Regarding Prenatal Testing: A Randomized Controlled Trial Using the Ottawa Decision Guide

Acronym

A Study on Counseling to Support Couples Who Are Considering Prenatal Testing

Scientific Title

Genetic Counseling to Support Couples' Decision-Making Regarding Prenatal Testing: A Randomized Controlled Trial Using the Ottawa Decision Guide

Scientific Title:Acronym

COUPLE-DECIDE RCT

Region

Japan


Condition

Condition

Couples without children

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to examine support for couples' decision-making regarding prenatal testing. Participants will be randomly assigned, with the intervention group receiving support using the Ottawa Decision Support Guide, and the control group receiving decision-making support without the use of the tool. The study aims to clarify differences between the two groups in decisional conflict, couples' communication attitudes, and the impact of reaching joint decisions on subsequent relationship quality. Findings are expected to inform genetic counseling, genetics education, and preconception care.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Couples' communication attitudes will be assessed using the Japanese version of the CPQ, with particular focus on the scores for "mutually constructive" and "constructive communication." These scores will be compared between the intervention and control groups. Participants will complete the Japanese CPQ at study enrollment, immediately after the intervention, and one month after the intervention.

Key secondary outcomes

Study participants will complete the Decisional Conflict Scale (DCS) immediately after the intervention. Scores on the DCS will be compared between the intervention and control groups.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

The intervention group will receive support for couples' decision-making using the Ottawa Decision Support Guide. The control group will receive decision-making support without using the Ottawa Decision Support Guide.

Interventions/Control_2

The intervention group will receive support for couples' decision-making using the Ottawa Decision Support Guide. The control group will receive decision-making support without using the Ottawa Decision Support Guide.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

Aged 18 years or older
Couples without children
Wife under 50 years of age
Couples married for 10 years or less

Key exclusion criteria

Couples who have children
Individuals who have experienced fertility treatment
Those who have previously received genetic counseling related to NIPT
Individuals who are unable to participate in the study online (e.g., cannot access Zoom or complete web-based questionnaires)

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Mikako
Middle name
Last name Miyata

Organization

Doctoral Program, Department of Nursing Science, Graduate School of Biomedical Sciences, Nagasaki University

Division name

Doctoral Program, Department of Nursing Science

Zip code

852-8520

Address

1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan

TEL

095-819-7907

Email

bb55319028@ms.nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Mikako
Middle name
Last name Miyata

Organization

Department of Nursing Science, Graduate School of Biomedical Sciences, Nagasaki University

Division name

Doctoral Program, Department of Nursing Science

Zip code

852-8520

Address

1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan

TEL

095-819-7907

Homepage URL


Email

bb55319028@ms.nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Graduate School of Biomedical Sciences, Health Science Courses, Ethics Committee.

Address

1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan

Tel

095-819-7907

Email

bb55319028@ms.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 10 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 09 Month 03 Day

Date of IRB

2025 Year 09 Month 04 Day

Anticipated trial start date

2025 Year 12 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 10 Month 20 Day

Last modified on

2025 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067826